Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas

Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas

in this resarch we will use ELISA Technique to estimate Human Transcriptional Activator(MYB) Expression .compare it by Immmunohistochemistry analysis of MYB Expression in the malignant and benign salivary gland tumor

Inclusion Criteria: .

• Patients with clinically evident salivary gland tumors; malignant tumors will be recruited in group I
• Benign tumors will be recruited in group II.

Exclusion Criteria:

• Subjects taking any drugs inducing any changes that could affect the salivary glands.
• Pregnant females.
• Subjects having any allergies, infectious or autoimmune diseases.
• Subjects having any metabolic disorders that can be manifested with salivary gland swelling as diabetes mellitus.